Veröffentlichungen
Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer
Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.
- [o.033] Kit Is Expressed by Epithelial Cells In Vivo (0)
- [o.270] Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador (0)
- [o.489] Label-free imaging of M1 and M2 macrophage phenotypes in the human dermis in vivo using two-photon excited FLIM (0)
- [o.038] Lack of significant skin inflammation during elimination by apoptosis of large numbers of mouse cutaneous mast cells after cessation of treatment with stem cell factor (2)
- [o.192] Lactic acid sting test does not differentiate between facial and generalized skin functional impairment in sensitive skin in atopic dermatitis and rosacea (0)
- [o.404] Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks (2)
- [o.450] Lanadelumab efficacy, safety, and injection interval extension in HAE – a real life study (1)
- [o.576] Lanadelumab in patients 2 to less than 12 years old with hereditary angioedema: results from the phase 3 SPRING study (0)
- [o.347] Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America (0)
- [o.086] Leitlinie Mastozytose (0)
- [o.268] Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis (0)
- [o.360] Ligelizumab for Chronic Spontaneous Urticaria (1)
- [o.512] Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria (0)
- [o.469] Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria (0)
- [o.541] Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis (0)
- [o.487] Long-term efficacy and safety of omalizumab monotherapy in a patient with normocomplementemic urticarial vasculitis (0)
- [o.389] Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome (2)
- [o.470] Long-term prevention of hereditary angioedema attacks with lanadelumab: the HELP OLE study (0)
- [o.100] Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis (0)
- [o.440] Long-term safety and effectiveness of berotralstat for hereditary angioedema: the open-label APeX-S study (0)
(Last update: 06.2024)
| Number of original publications in peer-reviewed journals: | 612 |
| Number of reviews in peer-reviewed journals: | 217 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 829 |
| Cumulative IF for original publications in peer-reviewed journals: | 4364.99 |
| Cumulative IF for reviews in peer-reviewed journals: | 1567.62 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5932.61 |
| Total number of citations: 37,066, h-index: 98 (Web of Science Juni 2024) | 37066 |
Download-Information
Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.